文献速递肝病

代谢功能障碍缓解改善中国儿童肝脏健康:两项前瞻性队列研究

Resolution of Metabolic Dysfunction Improves Liver Health Among Chinese Children: Evidence From Two Prospective Cohorts.
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-09-30

基于中国两项前瞻性队列共2158名6至11岁儿童、随访4年的数据,评估代谢功能障碍缓解与肝脏脂肪变风险的关系。随访期间10.4%儿童发生肝脏脂肪变,基线代谢功能障碍显著增加风险(OR 3.31),而代谢功能障碍缓解者风险未增加(OR 0.64)。结论提示代谢功能障碍是儿童肝脏脂肪变的强预测因素,其缓解可 attenuate 相关风险。

要点

  • 基线代谢功能障碍显著增加儿童肝脏脂肪变风险(OR 3.31,95%CI 2.42-4.52)。
  • 持续代谢功能障碍者风险最高(OR 6.01,95%CI 3.96-9.12)。
  • 代谢功能障碍缓解至正常者风险未增加(OR 0.64,95%CI 0.26-1.57)。

核心结论

  • 代谢功能障碍是儿童新发肝脏脂肪变的强预测因素,其缓解可减弱相关风险。

研究设计与样本

  • 基于中国2项前瞻性队列研究,纳入基线6至11岁儿童2158名,随访4年。

主要发现

  • 随访时10.4%儿童(n=225)发生肝脏脂肪变。
  • 基线代谢功能障碍显著增加肝脏脂肪变风险(OR 3.31;95%CI 2.42-4.52)。
  • 与持续代谢健康者相比,持续代谢功能障碍者风险显著增加(OR 6.01;95%CI 3.96-9.12)。
  • 随访时新发代谢功能障碍者风险亦增加(OR 1.99;95%CI 1.19-3.33)。
  • 代谢功能障碍缓解至正常者未见风险增加(OR 0.64;95%CI 0.26-1.57)。

临床怎么用

  • 针对代谢风险因素的一级和二级干预对改善儿童肝脏健康具有重要意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The new metabolic dysfunction-associated steatotic liver disease (MASLD) definition emphasizes the crucial role of metabolic dysfunction in MASLD pathogenesis. This study aimed to examine whether the resolution of metabolic dysfunction can mitigate the risk of hepatic steatosis in Chinese children. METHODS: Data were obtained from 2 prospective cohort studies in China, including 2158 children aged 6 to 11 years at baseline, with a 4-year follow-up. Based on metabolic status (normal vs abnormal) at baseline and follow-up, children were categorized into 4 distinct groups. Hepatic steatosis was assessed by abdominal ultrasonography and/or serum alanine aminotransferase measurements. RESULTS: At follow-up, 10.4% of children (n = 225) developed hepatic steatosis. Baseline metabolic dysfunction significantly increased the risk of incident hepatic steatosis (odds ratio [OR], 3.31; 95% confidence interval [CI], 2.42-4.52). Compared with children who kept metabolically healthy at both baseline and follow-up, those with persistent metabolic dysfunction (OR, 6.01; 95% CI, 3.96-9.12) and those who developed metabolic dysfunction at follow-up (OR, 1.99; 95% CI, 1.19-3.33) had significantly increased risks of hepatic steatosis. Notably, children whose metabolic dysfunction resolved to normal status at follow-up presented no increased risk (OR, 0.64; 95% CI, 0.26-1.57). CONCLUSIONS: Metabolic dysfunction is a strong predictor of incident hepatic steatosis in children, and resolution of this dysfunction attenuates the attendant risk. These findings highlight the importance of primary and secondary interventions targeting metabolic risk factors to improve liver health in children.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Yang L, Li M, Zhao M, et al. Resolution of Metabolic Dysfunction Improves Liver Health Among Chinese Children: Evidence From Two Prospective Cohorts. Clin Gastroenterol Hepatol. 2025. PMID: 41038414. doi:10.1016/j.cgh.2025.09.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。